Durable Tocilizumab Responses Seen in Trial Extensions of Polyarticular and Systemic JIA SubtypesApril 16, 2024Pediatrics
Clinical Characteristics of Chronic Nonbacterial Osteomyelitis Can Predict Therapy Needs Over TimeApril 3, 2024Pediatrics
Early Biologic Initiation Linked to Rapid Improvement of JIA, Sustained RemissionApril 1, 2024Pediatrics
Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous FormulationsMarch 8, 2024Rheumatoid ArthritisLupus & Connective Tissue DiseasesPediatrics
FDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPediatrics
What Markers Are Helpful to Diagnose Infection in Tocilizumab Users?February 23, 2024Rheumatoid ArthritisPediatricsLupus & Connective Tissue Diseases
Review Finds No Short-term MACE, VTE risk with JAK Inhibitors For DermatosesFebruary 5, 2024Mixed TopicsPediatricsPsoriatic Arthritis
Novel Solutions Needed to Attract Residents to Pediatric RheumatologyDecember 19, 2023PediatricsBusiness of Medicine
Teen and young adult rheumatology patients report gaps in sexual health counselingDecember 14, 2023Pediatrics
Rheumatology Match Day results for 2024 follow trends of past yearsNovember 30, 2023Business of MedicinePediatrics
Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?November 13, 2023Lupus & Connective Tissue DiseasesPediatrics
